The 5 Best Stocks 2024

 Buying stocks can be straightforward, but identifying the right ones without a solid strategy is challenging. Wondering which stocks to buy or add to your watchlist? Consider Microsoft (MSFT), Ares Management (ARES), Dexcom (DXCM), Square's parent company Block (SQ), and Shockwave Medical (SWAV) as top contenders.

Inflation concerns and aggressive Federal Reserve rate tightening unsettled investors last year. However, the market defied expectations and delivered impressive results in 2023. While 2024 forecasts suggest more moderate gains, there's growing confidence in the Fed's ability to achieve a soft landing.

Key Ingredients for Selecting the Best Stocks

With thousands of stocks traded on the NYSE and Nasdaq, pinpointing the best ones is crucial for significant gains. The CAN SLIM system provides clear guidelines for identifying potential winners. Focus on stocks with recent quarterly and annual earnings growth of at least 25%. Look for companies introducing innovative products or services, including newly public companies showing substantial revenue growth.

CAN SLIM consistently outperforms the S&P 500, emphasizing the importance of surpassing industry benchmarks for exceptional long-term returns. Additionally, monitor stock supply and demand, prioritize leading stocks in top industry groups, and seek stocks with robust institutional support.

After identifying suitable stocks, analyze stock charts to determine optimal entry points. Wait for stocks to form a base and buy once they reach a buy point, preferably with heavy volume. Keep a close eye on market trends, and invest during confirmed uptrends while moving to cash during corrections.

Top Stocks to Watch and Buy

Amid a confirmed uptrend in the stock market, investing in high-quality stocks is advisable. The following selections represent some of the best stocks to consider:

  • Microsoft
  • Ares Management
  • Dexcom
  • Block
  • Shockwave Medical

These stocks exhibit impressive relative strength and warrant closer examination.

Microsoft Stock Analysis

Microsoft has demonstrated notable performance, rebounding from the 10-week moving average and achieving a short consolidation. Key indicators, such as EPS growth and institutional interest, signal strong potential for continued success.

Ares Management Stock Analysis

Ares Management shows promising signs with a flat base formation and robust earnings performance. Despite industry challenges, the firm's diversified portfolio and substantial assets under management position it for continued growth.

Dexcom Stock Analysis

Dexcom's innovative glucose monitoring systems and solid financial performance make it a compelling investment option. The company's expansion into new markets and recent product approvals further enhance its growth prospects.

Block Stock Analysis

Block's success in digital payments and strategic acquisitions, such as Afterpay, underscores its growth trajectory. Strong earnings and revenue growth projections support its bullish outlook.

Shockwave Medical Stock Analysis

Despite recent setbacks, Shockwave Medical's pioneering technology and rebounding performance indicate potential for recovery. With favorable reimbursement trends and growing institutional interest, the company is poised for future growth.

Market Outlook and Conclusion

As the stock market continues its upward trajectory, investors should remain vigilant for potential sell signals. Implementing disciplined risk management practices, such as adhering to predetermined stop-loss levels, is essential to mitigate losses and protect gains.

While the current market environment appears favorable, external factors such as inflation and geopolitical tensions can introduce volatility. Stay informed and adapt investment strategies accordingly to navigate market uncertainties effectively.

In summary, by focusing on high-quality stocks with strong fundamentals and adhering to proven investment principles, investors can capitalize on market opportunities and achieve long-term financial success.

Top 5 Blue-Chip Stocks To Buy for February in 2012

These top five stocks for February have the immediate growth potential and are seeing exceptional buying pressure. I want to make certain you’re not missing out on these wonderful opportunities.
Two of the top five stocks for February are returning veterans from January and other months, but I’ve added some new stocks as well. Let’s get started:

Alexion Pharmaceuticals

Top 5 Blue-Chip Stocks To Buy for February in 2012 - Alexion (NASDAQ:ALXN) remains the No. 1 stock on my buy list. This stock has been surging higher in recent weeks, and shares responded very positively to the news that the company is expanding its product portfolio through its $1 billion bid for Enobia Pharma, a developer of therapies for serious genetic bone disorders. The company currently is working to get its hypophosphatasia treatment, asfotase alfa, approved in the United States. To date, there is no approved treatment for this life-threatening disease. So, if approved, the company would have a tremendous first-mover advantage. Alexion, who will acquire full worldwide development and commercial rights to asfotase alfa, is confident the drug can obtain approval. Analysts currently expect Alexion to grow sales by 41.4% and earnings by 30.8% in the fourth quarter. ALXN reports Thursday, Feb. 9.
AutoZone
Top 5 Blue-Chip Stocks To Buy for February in 2012 - AutoZone (NYSE:AZO) has taken off on its next leg higher because it is the perfect stock for the current automobile market. Although consumers are buying new cars when necessary, they also are extending the lives of those vehicles and getting as much mileage as they can for their buck. And companies like AutoZone do this superbly by supplying the parts to keep well-worn cars in top condition. Looking forward to the company’s next quarterly earnings report, expected in late February, analysts currently estimate AutoZone will announce 7% growth in sales and 19.8% growth in earnings. The stock should be a solid performer in the coming weeks. AZO is a strong buy.

Dollar Tree

Top 5 Blue-Chip Stocks To Buy for February in 2012 - Dollar Tree (NASDAQ:DLTR) knows one of the best ways of coping with thinning wallets is to stretch each and every dollar. So, while lean times hit other retailers particularly hard, Dollar Tree stores flourished. The company is the largest and most successful single-price-point retailer in the U.S. — everything in its 4,000 locations is just $1. The company has continued its success even as the U.S. economy improves, and I don’t believe the desire of consumers to save money will be disappearing anytime in 2012. In fact, analysts currently expect the company to report 11.5% sales growth and 22.5% earnings growth in its Feb. 22 earnings announcement.

McDonald’s

Top 5 Blue-Chip Stocks To Buy for February in 2012 - McDonald’s (NYSE:MCD) is the world’s No. 1 fast-food company and a solid winner for this buy list. Analysts expected the company to report 9.1% sales growth and 11.2% earnings growth this week. McDonald’s answered back by beating earnings expectations for 14th time in the past 16 quarters. Although this did not push the stock higher, I still believe the positive earnings report will be a catalyst for further gains. McDonald’s plans to invest in store expansions around the globe in 2012, with two-thirds of its new stores to be located in Asia.
Ross Stores
Top 5 Blue-Chip Stocks To Buy for February in 2012 - Ross Stores (NASDAQ:ROST) is the nation’s largest off-price apparel and home fashion retailer and continues to benefit from value-focused customers. The stock has been a solid performer so far in the new year. In December, ROST reported that its same-store sales jumped 9.2%, over double the 4% estimate! I’m looking forward to the company’s Q4 earnings announcement and finding out how these exceptional sales affected the company’s earnings. Analysts are currently expect the company to report 10.9% sales growth and 20.3% earnings growth, and a solid surprise could be just the ticket to the stock’s next leg higher.

Best Stocks to buy 2012 Labels